AGP Limited Stock

Equities

AGP

PK0113801010

Pharmaceuticals

End-of-day quote Pakistan S.E. 18:00:00 2024-04-25 EDT 5-day change 1st Jan Change
80.85 PKR -0.80% Intraday chart for AGP Limited -1.39% +14.99%

Financials

Sales 2024 * 19.43B 69.82M 95.43M Sales 2025 * - Capitalization 22.64B 81.34M 111M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.17 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * -
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 1,574
Yield 2024 *
4.64%
Yield 2025 *
-
Free-Float 16.07%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.80%
1 week-1.39%
Current month+8.93%
1 month+15.29%
3 months+17.38%
6 months+38.13%
Current year+14.99%
More quotes
1 week
80.05
Extreme 80.05
84.50
1 month
70.70
Extreme 70.7
84.50
Current year
60.21
Extreme 60.21
84.50
1 year
46.00
Extreme 46
84.50
3 years
46.00
Extreme 46
158.99
5 years
46.00
Extreme 46
158.99
10 years
46.00
Extreme 46
158.99
More quotes
Managers TitleAgeSince
Chief Executive Officer - 12-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 21-02-28
Members of the board TitleAgeSince
Director/Board Member - 18-06-06
Chief Executive Officer - 12-31
Director/Board Member - 15-11-29
More insiders
Date Price Change Volume
24-04-26 80.85 -0.80% 88,872
24-04-25 81.5 -1.58% 99,334
24-04-24 82.81 +1.53% 98,634
24-04-23 81.56 -1.39% 185,340
24-04-22 82.71 +0.88% 370,614

End-of-day quote Pakistan S.E., April 25, 2024

More quotes
AGP Limited is a Pakistan-based pharmaceutical company. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale, and manufacturing of all kinds of pharmaceutical products. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale, and manufacturing of various kinds of pharmaceutical products. It owns a range of products catering to distinct therapeutic needs of the market. It consists of Holding Company's pharmaceutical segment and related products, and OBS AGP's pharmaceutical segment. It offers a diverse portfolio of products in internal medicine, gynecology, pediatrics, nutraceutical, neuropsychiatry, cardiometabolic, hepatology, and orthopedic. Its products include Afdol, Nebcin, Exotan, Nergab, Febuxin, Zerifax, Protege, Maxna, and Rigix, among others. Its subsidiary includes OBS AGP (Private) Limited (OBS AGP). OBS AGP is in the business of trading pharmaceutical products.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
80.85 PKR
Average target price
100 PKR
Spread / Average Target
+23.69%
Consensus

Chiffre d''affaires - Rate of surprise